BSE filing, NSE: CONCORD. Summary written from the filing by ALFA Finder's alert engine.
Concord Drugs Ltd: key numbers
- Share price
- ₹63.55
- Market cap
- ₹83.73 Cr
- Revenue (annual)
- ₹78.74 Cr
- Net profit (annual)
- ₹1.06 Cr
- P/E (TTM)
- 40.8×Sector 45.9×
- Promoter holding
- 45.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Drugs Ltd
All →Concord Drugs Other Announcement
Concord Drugs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Concord Drugs Annual General Meeting
Concord Drugs Limited held its 31st Annual General Meeting on September 30, 2026. The meeting covered adoption of financial statements, director appointments, and auditor re-appointment.
Concord Drugs Other Announcement
Concord Drugs Limited is notifying shareholders about the annual report web-link as per Regulation 36(1)(b). Shareholders are urged to update their email addresses.
Concord Drugs Annual Report
Concord Drugs Limited submitted its 31st Annual Report for FY 2025-26 and notice of the 31st Annual General Meeting scheduled for 30th September 2026.
Concord Drugs Annual General Meeting
Concord Drugs approved the notice for its 31st AGM on September 30, 2026. The board also finalized director re-appointments and set book closure dates.
Concord Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 1000.0% YoY
Concord Drugs Ltd reported revenue from operations of ₹20.9 Cr (+53.7% YoY) and net profit of ₹1.1 Cr (+1000.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +1000.0% YoY
Other board meeting date announcements
All →Anna Infrastructures Board Meeting Date
Anna Infrastructures Ltd has intimated BSE of a board meeting on 12 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The notice also confirms the trading window stays closed until 48 hours after the meeting.
Garuda Construction and Engineering Board Meeting Date
Garuda Construction and Engineering will hold a board meeting on 04-Nov-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The filing is a prior intimation of the future meeting.
Exicom Tele-Systems Board Meeting Date
Exicom Tele-Systems will hold a board meeting on November 4, 2026 to consider Q2 and half-year unaudited results. The trading window will reopen on November 7, 2026.
Vidya Wires Board Meeting Date
Vidya Wires will hold a board meeting on November 4, 2026 to consider quarterly and half-year unaudited results. The trading window stays closed until 48 hours after the results are made public.
Abirami Financial Services (India) Board Meeting Date
Abirami Financial Services board meets 11 November 2026 to consider unaudited September 2026 quarterly results. Prior intimation; trading window closed from 1 October 2026.
Sunrise Efficient Marketing Board Meeting Date
Sunrise Efficient Marketing schedules a board meeting on 6 November 2026 for half-year results. Agenda also includes cash flow statement and limited review report.